A Prospective Randomized Controlled Multicenter Phase-III Clinical Study to Evaluate the Safety and Effectiveness of NOVOCART 3D Plus Compared to the Standard Procedure Microfracture in the Treatment of Articular Cartilage Defects of the Knee

Trial Profile

A Prospective Randomized Controlled Multicenter Phase-III Clinical Study to Evaluate the Safety and Effectiveness of NOVOCART 3D Plus Compared to the Standard Procedure Microfracture in the Treatment of Articular Cartilage Defects of the Knee

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 15 Feb 2018

At a glance

  • Drugs Autologous chondrocyte implant TETEC (Primary)
  • Indications Cartilage disorders
  • Focus Therapeutic Use
  • Sponsors TETEC
  • Most Recent Events

    • 12 Feb 2018 Planned End Date changed from 1 Jun 2019 to 1 May 2021.
    • 12 Feb 2018 Status changed from recruiting to active, no longer recruiting.
    • 17 Jan 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top